You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for New Drug Application (NDA): 208813


✉ Email this page to a colleague

« Back to Dashboard


NDA 208813 describes TOREMIFENE CITRATE, which is a drug marketed by MSN and Rising and is included in two NDAs. It is available from three suppliers. Additional details are available on the TOREMIFENE CITRATE profile page.

The generic ingredient in TOREMIFENE CITRATE is toremifene citrate. There are five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the toremifene citrate profile page.
Summary for 208813
Tradename:TOREMIFENE CITRATE
Applicant:Rising
Ingredient:toremifene citrate
Patents:0
Pharmacology for NDA: 208813
Suppliers and Packaging for NDA: 208813
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOREMIFENE CITRATE toremifene citrate TABLET;ORAL 208813 ANDA Rising Pharmaceuticals, Inc. 64980-404 64980-404-03 30 TABLET in 1 BOTTLE, PLASTIC (64980-404-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 60MG BASE
Approval Date:Dec 4, 2018TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.